Jia Yi Fan, Chen Sheng, Wen Zhi Hong, Xie Qi, Zhao Ji Ping
Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Beijing 100730, China.
Department of Acupuncture and Moxibustion, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700.
Zhen Ci Yan Jiu. 2020 Jan 25;45(1):46-50. doi: 10.13702/j.1000-0607.1904286.
To observe the clinical effect of herbal cake-partitioned moxibustion combined with Rhinocort spray in the treatment of symptoms, sleep quality and daily life quality of patients with moderate-severe allergic rhinitis(AR)..
A total of 67 patients with persistent moderate-severe AR were recruited in the present study and randomized into a treatment group (=35) and a control group (=32). The patients in the treatment group were treated by herbal cake-partitioned moxibustion (applied to Dazhui [GV14], and bilateral Feishu [BL13], Shenshu [BL23] and Zhiyang [GV9], 3 moxa-cones/time, once every other day) plus Rhinocort spray (once in the morning and evening separately, 256 µg/d), and patients in the control group treated by Rhinocort spray alone (the same to that mentioned above). All the treatments were given for 4 weeks. The therapeutic effect was evaluated with reference to the "Principles and Recommended Schemes for Diagnosis and Treatment of AR" formulated by Otolaryngology Branch of Chinese Medical Association before and after the treatment. The severity of symptoms of AR was assessed by using visual analogue scale (VAS), the life quality of nasal conjunctivitis assessed using "Rhino-conjunctivitis Quality of Life Questionnaire (RQLQ)", and the sleep quality assessed using "Pittsburgh Sleep Quality Index (PSQI)" before and after the treatment, followed by 3 months' follow-up survey.
After the treatment, the VAS and RQLQ scores in both groups and PSQI of the treatment group were significantly decreased in comparison with their own base-line levels of pre-treatment in each group (<0.05). The RQLQ and PSQI in the treatment group were substantially lower than those in the control group (<0.05). No marked difference was found between the two groups in VAS(>0.05). Follow-up survey showed that the VAS and RQLQ scores in both groups and PSQI of the treatment group were still significantly lower than those of pre-treatment in each group(<0.05), and the VAS, RQLQ and PSQI scores of the treatment group were significantly lower than those of the control group(<0.05). After 4 weeks' treatment, of the 32 and 35 AR patients in the control and treatment groups, 7 and 16 experienced marked improvement, 16 and 14 were effective, and 9 and 5 failed, with the effective rate being 71.9% and 85.7%, respectively. The effective rate of the treatment group was significantly superior to that of the control group (<0.05).
Herbal cake-partitioned moxibustion combined with Rhinocort spray has a good therapeutic effect in improving symptoms, sleep and quality of life in patients with persistent moderate-severe AR, which is obviously superior to that of Rhinocort spray alone in improving sleep and quality of life.
观察隔药饼灸联合雷诺考特鼻喷雾剂对中重度变应性鼻炎(AR)患者症状、睡眠质量及日常生活质量的临床疗效。
选取67例持续性中重度AR患者,随机分为治疗组(n=35)和对照组(n=32)。治疗组采用隔药饼灸(灸大椎、双侧肺俞、肾俞、至阳,每次3壮,隔日1次)联合雷诺考特鼻喷雾剂(早晚各1次,256μg/d)治疗,对照组单纯采用雷诺考特鼻喷雾剂(用法同治疗组)治疗。两组均治疗4周。参照中华医学会耳鼻咽喉头颈外科学分会制定的《变应性鼻炎诊断和治疗指南》对两组患者治疗前后进行疗效评价。采用视觉模拟评分法(VAS)评估AR症状严重程度,采用“鼻结膜炎生活质量问卷(RQLQ)”评估鼻结膜炎患者生活质量,采用“匹兹堡睡眠质量指数(PSQI)”评估治疗前后睡眠质量,并进行3个月的随访调查。
治疗后,两组VAS、RQLQ评分及治疗组PSQI评分较各自治疗前基线水平均显著降低(P<0.05)。治疗组RQLQ、PSQI评分显著低于对照组(P<0.05)。两组VAS评分比较,差异无统计学意义(P>0.05)。随访调查显示,两组VAS、RQLQ评分及治疗组PSQI评分仍显著低于各自治疗前水平(P<0.05),且治疗组VAS、RQLQ、PSQI评分显著低于对照组(P<0.05)。治疗4周后,对照组32例、治疗组35例AR患者中,显效分别为7例和16例,有效分别为16例和14例,无效分别为9例和5例,有效率分别为71.9%和85.7%。治疗组有效率显著高于对照组(P<0.05)。
隔药饼灸联合雷诺考特鼻喷雾剂对持续性中重度AR患者症状、睡眠及生活质量具有良好的改善作用,在改善睡眠和生活质量方面明显优于单纯使用雷诺考特鼻喷雾剂。